Check out Accepted Articles, the new rapid publication service in Wiley InterScience

European Journal of Haematology

Edited by:
Niels Borregaard

ISI Journal Citation Reports® Ranking: 2008: 39/62 Hematology
Impact Factor: 2.237

Why read or submit to the European Journal of Haematology?

• Accepted Articles Published Online ahead of Print - Articles in this journal which have been peer-reviewed and accepted, but not yet copy-edited, are published online through our AcceptedArticles feature in advance of print publication - click here to see the articles currently available
• Average time from submission to acceptance is now 4.2 weeks

• Online Submission - to submit your manuscript click here
• Online article tracking via Wiley-Blackwell's Author Services - Enables authors to track their article through the production process to publication online and in print - for more information click here
• Authors receive a 50% discount on the subscription prices
  

TopNews and Announcements

Accepted Articles Published Online ahead of Print
Articles in this journal which have been peer-reviewed and accepted, but not yet copy-edited, are published online through our Accepted Articles feature in advance of print publication - click here to see the articles currently available

Free Access in the Developing World
Free online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).

Online Open
Authors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee. Read more.

NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement.

TopHighlights

Read these top downloaded articles from 2008 FREE!

Multiple myeloma - an update on diagnosis and treatment
Jo Caers, Isabelle Vande Broek, Hendrik De Raeve et al

Differential expression of microRNAs in hematopoietic cell lineages
Michaela Merkerova, Monika Belickova, Hana Bruchova

Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results
Marta Medeot, Francesco Zaja, Nicola Vianelli et al

A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma
Marie von Lilienfeld-Toal, Corinna Hahn-Ast, Kerstin Furkert et al